Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Identification of Immunogenic Neo-epitopes for the Development of Personalised Pancreatic Cancer Vaccines

NCT04379960 is registered in ClinicalTrials.gov with Queen Mary University of London as lead sponsor.

NCT NCT04379960
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04379960 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Identification of Immunogenic Neo-epitopes for the Development of Personalised Pancreatic Cancer Vaccines
Lead sponsor
Queen Mary University of London
Phase
Observational
Overall status
Completed
Start date
September 30, 2016
Completion date
October 31, 2021
Enrollment
192 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

the initial aim of this project is to perform in vitro validation of neoepitope candidates selected from available mutanome data